| scholarly article | Q13442814 |
| P50 | author | Marcus Buggert | Q47258443 |
| David F G Malone | Q57430278 | ||
| Marianne Jansson | Q61755906 | ||
| Annika C Karlsson | Q88351834 | ||
| Susanna M Bächle | Q117485268 | ||
| Johan K Sandberg | Q40143017 | ||
| P2093 | author name string | Patrik Medstrand | |
| Markus Moll | |||
| Antonio J Biague | |||
| Hans Norrgren | |||
| Per-Erik Isberg | |||
| SWEGUB CORE group | |||
| P2860 | cites work | Emerging concepts in the immunopathogenesis of AIDS | Q22241984 |
| Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 | ||
| The transcription factor PLZF directs the effector program of the NKT cell lineage | Q24654999 | ||
| Transcriptional regulation of the NKT cell lineage | Q27012749 | ||
| Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection | Q28271332 | ||
| Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda | Q33654658 | ||
| Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection | Q41842825 | ||
| The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation | Q42212740 | ||
| Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals | Q42219856 | ||
| Activation of NK cells is associated with HIV-1 disease progression | Q42244605 | ||
| Prevalence and incidence of HIV-1 and HIV-2 before, during and after a civil war in an occupational cohort in Guinea-Bissau, West Africa. | Q42624320 | ||
| T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study | Q43786352 | ||
| Optimal cellular preservation for high dimensional flow cytometric analysis of multicentre trials | Q43914078 | ||
| Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau | Q44430005 | ||
| HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127. | Q44519131 | ||
| Direct relationship between virus load and systemic immune activation in HIV-2 infection | Q45247367 | ||
| Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection | Q45739618 | ||
| Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. | Q45980825 | ||
| Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection. | Q46002704 | ||
| HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau | Q46934795 | ||
| Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia | Q46973654 | ||
| Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. | Q47439250 | ||
| T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells | Q47765721 | ||
| Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections | Q47988143 | ||
| Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa | Q50659100 | ||
| CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. | Q52010705 | ||
| CD56 negative NK cells: origin, function, and role in chronic viral disease | Q56953283 | ||
| Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load | Q58034113 | ||
| Microbial Translocation Correlates with the Severity of Both HIV‐1 and HIV‐2 Infections | Q58320032 | ||
| Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation | Q61718753 | ||
| Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors | Q69889335 | ||
| Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity | Q71726450 | ||
| A subset of CD4+ thymocytes selected by MHC class I molecules | Q72671900 | ||
| Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection | Q77296161 | ||
| Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection | Q77522486 | ||
| Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals | Q95801301 | ||
| T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection | Q33916550 | ||
| Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village | Q33919925 | ||
| Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient | Q34019039 | ||
| Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics | Q34034072 | ||
| Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis | Q34035802 | ||
| Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions | Q34323476 | ||
| Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection | Q34342894 | ||
| Immune activation and HIV persistence: implications for curative approaches to HIV infection | Q34351320 | ||
| Invariant NKT cells: regulation and function during viral infection | Q34390484 | ||
| Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall. | Q34434825 | ||
| Changes in Natural Killer cell activation and function during primary HIV-1 Infection | Q34551274 | ||
| Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection | Q34604276 | ||
| HIV-associated chronic immune activation | Q34653277 | ||
| Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes | Q35665765 | ||
| Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1 | Q35665921 | ||
| T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells | Q35848548 | ||
| Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection | Q35970916 | ||
| Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy | Q36304297 | ||
| Defective natural immunity: an early manifestation of human immunodeficiency virus infection | Q36365332 | ||
| CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection | Q36370230 | ||
| PLZF Controls the Expression of a Limited Number of Genes Essential for NKT Cell Function | Q36482182 | ||
| Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent | Q36506821 | ||
| Polyfunctional T cell responses are a hallmark of HIV-2 infection | Q36618086 | ||
| Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection. | Q36634790 | ||
| T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow | Q37630226 | ||
| Development of PLZF-expressing innate T cells | Q37831694 | ||
| Control of human viral infections by natural killer cells | Q38072477 | ||
| T-bet: a bridge between innate and adaptive immunity. | Q38151473 | ||
| Molecular and transcriptional basis of CD4⁺ T cell dysfunction during chronic infection | Q38812394 | ||
| CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? | Q38875947 | ||
| CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection | Q39006369 | ||
| HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1 | Q39348736 | ||
| Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection | Q39451862 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 1713-1722 | |
| P577 | publication date | 2016-05-09 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections | |
| P478 | volume | 30 |
| Q52332737 | CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil". |
| Q37312729 | CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection |
| Q55000980 | Functional Invariant Natural Killer T Cells Secreting Cytokines Are Associated With Non-Progressive Human Immunodeficiency Virus-1 Infection but Not With Suppressive Anti-Retroviral Treatment. |
| Q89530689 | HIV treatment in Guinea-Bissau: room for improvement and time for new treatment options |
| Q93104023 | HIV-2 as a model to identify a functional HIV cure |
| Q90050669 | High Activation of γδ T Cells and the γδ2pos T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK |
| Q90822890 | Immune response to a Tdap booster in vertically HIV-infected adolescents |
| Q92130709 | Immunological profiles of HIV-positive recipients of liver transplant |
| Q36246252 | Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression. |
| Q33390790 | Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion |
| Q37721215 | Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression |
Search more.